Chemistry:Deschloroketamine

From HandWiki
Short description: Chemical compound
Deschloroketamine
Deschloroketamine.png
Deschloroketamine3d.png
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC13H17NO
Molar mass203.285 g·mol−1
3D model (JSmol)

Deschloroketamine (DXE, DCK, 2'-Oxo-PCM) is a dissociative anesthetic[1][2] that has been sold online as a designer drug.[3][4][5][6][7] It has also been proposed for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation at doses of 2 mg per day.[8]

History

In 2019, it became part of a group of molecules studied by the French laboratory Caulredaitens.[citation needed]

Legal status

Deschloroketamine is illegal in Latvia,[9] and is covered by blanket bans in Canada and the UK.[citation needed]

See also

References

  1. "Synthesis and in vitro evaluation of (18)F-labelled S-fluoroalkyl diarylguanidines: Novel high-affinity NMDA receptor antagonists for imaging with PET". Bioorganic & Medicinal Chemistry Letters 20 (5): 1749–51. March 2010. doi:10.1016/j.bmcl.2010.01.052. PMID 20138515. 
  2. Stevens CL, "Aminoketones and methods for their production", US patent 3254124, published 31 May 1966
  3. "Characterization of the designer drug deschloroketamine (2-methylamino-2-phenylcyclohexanone) by gas chromatography/mass spectrometry, liquid chromatography/high-resolution mass spectrometry, multistage mass spectrometry, and nuclear magnetic resonance". Rapid Communications in Mass Spectrometry 30 (1): 151–60. January 2016. doi:10.1002/rcm.7425. PMID 26661982. Bibcode2016RCMS...30..151F. 
  4. "Alerta: descloroketamina vendida como ketamina en Barcelona" (in Spanish). Energy Control. https://energycontrol.org/analisis-de-sustancias/resultados/alertas/560-alerta-descloroketamina-vendida-como-ketamina-en-barcelona.html. 
  5. Villalba, Juanjo (27 March 2015). "Los efectos desconocidos de la sequía de ketamina" (in Spanish). Vice. https://www.vice.com/es/read/los-efectos-desconocidos-de-la-sequia-de-ketamina-719. 
  6. Knibbs, Jeremy (22 October 2015). "Party-drug testing shows its worth". The Medical Republic. http://www.medicalrepublic.com.au/953-2/. 
  7. "Synthesis and identification of deschloroketamine metabolites in rats' urine and a quantification method for deschloroketamine and metabolites in rats' serum and brain tissue using liquid chromatography tandem mass spectrometry". Drug Testing and Analysis 12 (3): 343–360. October 2019. doi:10.1002/dta.2726. PMID 31670910. 
  8. Preiss D, Tatar A, "Use of 2-methylamino-2-phenylcyclohexanone for the treatment of bacterial, fungal, viral or protozoal infections and for immunomodulation", DE patent 4409671, published 23 May 1995
  9. "Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem" (in Latvian). Ministry of Health of the Republic of Latvia. http://www.vm.gov.lv/images/userfiles/metodiskas_vadlinijas_080914.doc.